Why we're cautious about 2015: Germany's Merck
March 03, 2015 at 04:10 AM EST
Stiff competition for its biggest drug and high research and development costs have pushed Merck to adopt a cautious outlook, the German firm said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.